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DruQuaR
Somatropin is a recombinant human growth hormone, consisting of 191 amino acids [1]. This protein is clinically used in children and adults with
inadequate endogenous growth hormone to stimulate a normal bone and muscle growth. In addition, somatropin is currently being investigated for the
diagnosis and radiotherapy of certain hormonal cancers. The modification of the protein with the chelating agent NOTA (1,4,7-triazacyclononane-1,4,7-
triacetic acid) allows the inclusion of metals coupled to the protein for diagnostic (e.g. 68Ga) or therapeutic (e.g. 90Y) purposes. The NOTA unit is selectively
introduced on a lysine side chain. This yields 9 possible labelling sites for somatropin:
FPTIPLSRLFDNAMLRAHRLHQLAFDTYQEFEEAYIPK38EQK41YSFLQNPQTSLCFSESIPTPSNREETQQK70SNLELLRISLLLIQSWLEPVQFLRSVFANSLV
YGASDSNVYDLLK115DLEEGIQTLMGRLEDGSPRTGQIFK140QTYSK145FDTNSHNDDALLK158NYGLLYCFRK168DMDK172VETFLRIVQCRSVEGSCGF
The Ph. Eur. describes the selective cleavage of somatropin, using trypsin, as an identification test with a coverage of 95% [1]. As we were only interested
in the modified lysine amino acids, we have investigated different immobilized proteolytic enzymes: trypsin, chymotrypsin and Staphylococcus aureus V-8
proteases. The resulting peptides were then monitored using HPLC-MS2, allowing the characterisation of the modified protein.
After p-SCN-Bn-NOTA labelling of somatropin, the cysteine residues were reduced and alkylated using dithiothreitol (DTT) and iodoacetamide,
respectively. The solution was then desalted, using a PD-10 desalting column. Subsequently, an aliquot of the solution was incubated with trypsin (4 hours,
37°C), chymotrypsin (24 hours, 37°C) and Staphylococcus aureus V-8 (18 hours, 37°C) proteases. In addition, a mixture of trypsin and chymotrypsin was
added to the protein and incubated for 24 hours at 37°C.
EXPERIMENTAL 
[1] European Pharmacopoeia 6.0, 01/2008:0951.
RESULTS and DISCUSSION 
Staphylococcus aureus V-8 protease digestion of somatropin is unsuitable for localisation of modified lysine amino acids, as the lysine coverage is 
inadequate. Chymotrypsin and trypsin digestion are thus the most appropriate methods for establishing the NOTA-attached lysine amino acids. A 
combination of these enzymes is useful to discover the most abundant modified lysine amino acid, namely Lys70.
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Trypsin protease:
- Serine protease
- Cleaves at carboxyl side of K and R
- Theoretically: 21 fragments for 
somatropin
Chymotrypsin protease:
- Serine protease
- Cleaves at carboxyl side of F, Y and W
- Theoretically: 21 fragments for 
somatropin
Staphylococcus aureus V-8 protease:
- Serine protease
- Cleaves at carboxyl side of E and D
- Theoretically: 12 fragments for 
somatropin
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Mixture: trypsin + chymotrypsin
NOTA-labelled peptide HPLC:
Lysine coverage:
- Unlabelled: 100%
- NOTA-labelled: 100%, 
4 NOTA-modified Lys: 
Lys70 (63.84%), Lys158 (26.40%), 
Lys140 (4.42%), Lys172 (5.34%)
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Lysine coverage:
- Unlabelled: 89%
- NOTA-labelled: 67%,
2 NOTA-modified Lys: 
Lys70 (79.58%), Lys140 (20.42%)
Lysine coverage:
- Unlabelled: 22%
- NOTA-labelled: 22%, 
no NOTA-modified Lys found
Lysine coverage of NOTA-labelled: 89%,
3 NOTA-modified Lys:
Lys70 (59.37%), Lys140 (18.06%), 
Lys172 (22.57%)
